Log In
BCIQ
Print this Print this
 

flopristin/linopristin (NXL103) (formerly XRP2868)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionStreptogramin antibiotic
Molecular Target Ribosomal 50S subunit
Mechanism of ActionRibosomal 50S subunit inhibitor
Therapeutic ModalityMacrocycle

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today